Inhibition of Ebola Virus by a Molecularly Engineered Banana Lectin

Ebolaviruses cause an often rapidly fatal syndrome known as Ebola virus disease (EVD), with average case fatality rates of ~50%. There is no licensed vaccine or treatment for EVD, underscoring the urgent need to develop new anti-ebolavirus agents, especially in the face of an ongoing outbreak in the...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:PLoS Negl Trop Dis
Κύριοι συγγραφείς: Covés-Datson, Evelyn M., Dyall, Julie, DeWald, Lisa Evans, King, Steven R., Dube, Derek, Legendre, Maureen, Nelson, Elizabeth, Drews, Kelly C., Gross, Robin, Gerhardt, Dawn M., Torzewski, Lisa, Postnikova, Elena, Liang, Janie Y., Ban, Bhupal, Shetty, Jagathpala, Hensley, Lisa E., Jahrling, Peter B., Olinger, Gene G., White, Judith M., Markovitz, David M.
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Public Library of Science 2019
Θέματα:
Research Article
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6687191/
https://ncbi.nlm.nih.gov/pubmed/31356611
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0007595
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια